Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells.

Woodward WA, Chen MS, Behbod F, Alfaro MP, Buchholz TA, Rosen JM.

Proc Natl Acad Sci U S A. 2007 Jan 9;104(2):618-23. Epub 2007 Jan 3. Erratum in: Proc Natl Acad Sci U S A. 2007 Apr 24;104(17):7307.

2.

Wnt/beta-catenin mediates radiation resistance of Sca1+ progenitors in an immortalized mammary gland cell line.

Chen MS, Woodward WA, Behbod F, Peddibhotla S, Alfaro MP, Buchholz TA, Rosen JM.

J Cell Sci. 2007 Feb 1;120(Pt 3):468-77. Epub 2007 Jan 16.

3.

Small molecule antagonists of the Wnt/β-catenin signaling pathway target breast tumor-initiating cells in a Her2/Neu mouse model of breast cancer.

Hallett RM, Kondratyev MK, Giacomelli AO, Nixon AM, Girgis-Gabardo A, Ilieva D, Hassell JA.

PLoS One. 2012;7(3):e33976. doi: 10.1371/journal.pone.0033976. Epub 2012 Mar 28.

4.

Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium.

Meier-Abt F, Milani E, Roloff T, Brinkhaus H, Duss S, Meyer DS, Klebba I, Balwierz PJ, van Nimwegen E, Bentires-Alj M.

Breast Cancer Res. 2013 Apr 29;15(2):R36. doi: 10.1186/bcr3419.

5.

Regulation of mammary stem/progenitor cells by PTEN/Akt/beta-catenin signaling.

Korkaya H, Paulson A, Charafe-Jauffret E, Ginestier C, Brown M, Dutcher J, Clouthier SG, Wicha MS.

PLoS Biol. 2009 Jun 2;7(6):e1000121. doi: 10.1371/journal.pbio.1000121. Epub 2009 Jun 2.

6.

Wnt signaling, stem cells, and the cellular origin of breast cancer.

Lindvall C, Bu W, Williams BO, Li Y.

Stem Cell Rev. 2007 Jun;3(2):157-68. Review.

PMID:
17873348
7.

Caveolin-1-deficient mice have an increased mammary stem cell population with upregulation of Wnt/beta-catenin signaling.

Sotgia F, Williams TM, Cohen AW, Minetti C, Pestell RG, Lisanti MP.

Cell Cycle. 2005 Dec;4(12):1808-16. Epub 2005 Dec 22.

PMID:
16294019
8.

Key signaling nodes in mammary gland development and cancer: β-catenin.

Incassati A, Chandramouli A, Eelkema R, Cowin P.

Breast Cancer Res. 2010;12(6):213. doi: 10.1186/bcr2723. Epub 2010 Nov 3. Review.

9.

Wnt and mammary stem cells: hormones cannot fly wingless.

Roarty K, Rosen JM.

Curr Opin Pharmacol. 2010 Dec;10(6):643-9. doi: 10.1016/j.coph.2010.07.004. Review.

10.

Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression.

Chen F, Li A, Gao S, Hollern D, Williams M, Liu F, VanSickle EA, Andrechek E, Zhang C, Yang C, Luo R, Xiao H.

Cell Death Dis. 2014 May 22;5:e1242. doi: 10.1038/cddis.2014.224.

11.

Wnt/beta-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells.

Yang W, Yan HX, Chen L, Liu Q, He YQ, Yu LX, Zhang SH, Huang DD, Tang L, Kong XN, Chen C, Liu SQ, Wu MC, Wang HY.

Cancer Res. 2008 Jun 1;68(11):4287-95. doi: 10.1158/0008-5472.CAN-07-6691.

12.
13.

c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer.

Regan JL, Kendrick H, Magnay FA, Vafaizadeh V, Groner B, Smalley MJ.

Oncogene. 2012 Feb 16;31(7):869-83. doi: 10.1038/onc.2011.289. Epub 2011 Jul 18.

PMID:
21765473
14.

Wnt activation is implicated in glioblastoma radioresistance.

Kim Y, Kim KH, Lee J, Lee YA, Kim M, Lee SJ, Park K, Yang H, Jin J, Joo KM, Lee J, Nam DH.

Lab Invest. 2012 Mar;92(3):466-73. doi: 10.1038/labinvest.2011.161. Epub 2011 Nov 14.

15.

Myc is required for β-catenin-mediated mammary stem cell amplification and tumorigenesis.

Moumen M, Chiche A, Decraene C, Petit V, Gandarillas A, Deugnier MA, Glukhova MA, Faraldo MM.

Mol Cancer. 2013 Oct 30;12(1):132. doi: 10.1186/1476-4598-12-132.

16.

Chromatin effector Pygo2 mediates Wnt-notch crosstalk to suppress luminal/alveolar potential of mammary stem and basal cells.

Gu B, Watanabe K, Sun P, Fallahi M, Dai X.

Cell Stem Cell. 2013 Jul 3;13(1):48-61. doi: 10.1016/j.stem.2013.04.012. Epub 2013 May 16.

17.

The Wnt-β-catenin pathway represses let-7 microRNA expression through transactivation of Lin28 to augment breast cancer stem cell expansion.

Cai WY, Wei TZ, Luo QC, Wu QW, Liu QF, Yang M, Ye GD, Wu JF, Chen YY, Sun GB, Liu YJ, Zhao WX, Zhang ZM, Li BA.

J Cell Sci. 2013 Jul 1;126(Pt 13):2877-89. doi: 10.1242/jcs.123810. Epub 2013 Apr 23.

18.

Targeted activation of beta-catenin signaling in basal mammary epithelial cells affects mammary development and leads to hyperplasia.

Teulière J, Faraldo MM, Deugnier MA, Shtutman M, Ben-Ze'ev A, Thiery JP, Glukhova MA.

Development. 2005 Jan;132(2):267-77. Epub 2004 Dec 8.

19.

Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression.

Nguyen A, Rosner A, Milovanovic T, Hope C, Planutis K, Saha B, Chaiwun B, Lin F, Imam SA, Marsh JL, Holcombe RF.

Int J Oncol. 2005 Oct;27(4):949-56.

PMID:
16142310
20.

Wnt/beta-catenin signaling in murine hepatic transit amplifying progenitor cells.

Hu M, Kurobe M, Jeong YJ, Fuerer C, Ghole S, Nusse R, Sylvester KG.

Gastroenterology. 2007 Nov;133(5):1579-91. Epub 2007 Aug 28.

PMID:
17983805

Supplemental Content

Support Center